Shares of Moderna Inc. MRNA, -1.55% slid 1.55% to $176.81 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP, +0.99% rising 0.99% to 11,285.32 and the Dow Jones Industrial Average DJIA, +0.28% rising 0.28% to 34,194.06. Moderna Inc. closed $199.84 short of its 52-week high ($376.65), which the company reached on November 29th.
The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc. ABBV, -0.25% fell 0.25% to $159.39, Amgen Inc. AMGN, -1.27% fell 1.27% to $283.40, and AstraZeneca PLC ADR AZN, +0.18% rose 0.18% to $66.12. Trading volume (2.3 M) remained 2.8 million below its 50-day average volume of 5.1 M.